$1.49 Earnings Per Share Expected for Walgreens Boots Alliance Inc (WBA) This Quarter

Brokerages predict that Walgreens Boots Alliance Inc (NASDAQ:WBA) will post earnings of $1.49 per share for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have made estimates for Walgreens Boots Alliance’s earnings, with the highest EPS estimate coming in at $1.58 and the lowest estimate coming in at $1.43. Walgreens Boots Alliance posted earnings per share of $1.33 during the same quarter last year, which would indicate a positive year-over-year growth rate of 12%. The business is expected to issue its next earnings report on Thursday, July 5th.

On average, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.91 per share for the current year, with EPS estimates ranging from $5.58 to $6.00. For the next fiscal year, analysts anticipate that the firm will post earnings of $6.49 per share, with EPS estimates ranging from $6.08 to $6.74. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that follow Walgreens Boots Alliance.

How to Become a New Pot Stock Millionaire

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. The company had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. Walgreens Boots Alliance’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period last year, the business earned $1.36 EPS.

WBA has been the subject of several research reports. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research note on Saturday, April 7th. Jefferies Group set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, April 3rd. Scotiabank decreased their price objective on shares of Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating for the company in a research note on Monday, April 2nd. Finally, Pivotal Research set a $70.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Thursday, March 29th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus price target of $83.20.

WBA stock opened at $63.82 on Friday. The company has a market capitalization of $63,506.27, a P/E ratio of 12.51, a P/E/G ratio of 1.03 and a beta of 1.16. The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 52 week low of $61.74 and a 52 week high of $87.79.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 31.37%.

In other news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 14.80% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of WBA. Parkside Investments LLC grew its holdings in shares of Walgreens Boots Alliance by 3.0% during the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock worth $1,801,000 after buying an additional 715 shares in the last quarter. BTIM Corp. boosted its position in shares of Walgreens Boots Alliance by 3.5% during the 4th quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after acquiring an additional 725 shares during the last quarter. Eads & Heald Investment Counsel boosted its position in shares of Walgreens Boots Alliance by 3.6% during the 4th quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after acquiring an additional 748 shares during the last quarter. Iberiabank Corp boosted its position in shares of Walgreens Boots Alliance by 7.0% during the 3rd quarter. Iberiabank Corp now owns 11,474 shares of the pharmacy operator’s stock valued at $886,000 after acquiring an additional 753 shares during the last quarter. Finally, IFM Investors Pty Ltd boosted its position in shares of Walgreens Boots Alliance by 3.0% during the 3rd quarter. IFM Investors Pty Ltd now owns 25,769 shares of the pharmacy operator’s stock valued at $1,990,000 after acquiring an additional 762 shares during the last quarter. 60.90% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.thelincolnianonline.com/2018/04/14/1-49-earnings-per-share-expected-for-walgreens-boots-alliance-inc-wba-this-quarter.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply